Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about STING: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
STING (TMEM173) is a critical innate immune sensor linking cytosolic DNA sensing to neuroinflammation in Alzheimer's, Parkinson's, and other neurodegenerative diseases.
No AI portrait yet
| Gene Symbol | STING |
| Full Name | Stimulator of Interferon Genes |
| Aliases | TMEM173 |
| Chromosome | 5q31.2 |
| Function | is a transmembrane protein that serves as the central signaling hub for the cGAS-STING pathway, one of the most important innate immune sensing mechanisms in eukaryotic cells. |
| Molecular Weight | 42 kDa |
| Amino Acids | 379 aa |
| Exons | 6 |
| Pathways | NF-κB |
| UniProt ID | Q86WV1 |
| NCBI Gene ID | 340061 |
| Ensembl ID | ENSG00000184584 |
| OMIM | 612374 |
| GeneCards | STING |
| Human Protein Atlas | STING |
| Associated Diseases | AD, aging, ALI, Als |
| Known Drugs/Compounds | 2'3'-cGAMP, 2'3'-Cgamp, ADUCANUMAB, curcumin, CURCUMIN, dasatinib |
| Interactions | AB, ACHE, ACSL4, Actin, AD, ADAM10 |
| KG Connections | 3515 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
STING["STING"] -->|"activates"| type_I_interferon["type I interferon"]
STING["STING"] -->|"degrades"| GPX4["GPX4"]
STING["STING"] -->|"causes"| ferroptosis["ferroptosis"]
STING["STING"] -->|"activates"| LRRK2["LRRK2"]
STING["STING"] -->|"produces"| type_I_interferon_1["type I interferon"]
STING["STING"] -->|"produces"| inflammatory_cytokines["inflammatory cytokines"]
cGAMP["cGAMP"] -->|"activates"| STING["STING"]
substance_P["substance P"] -.->|"inhibits"| STING["STING"]
cGAS["cGAS"] -->|"activates"| STING["STING"]
NBR1["NBR1"] -.->|"inhibits"| STING["STING"]
style STING fill:#4a1a6b,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| CGAS-STING | activates | gene | 1.00 |
| Inflammation | inhibits | disease | 1.00 |
| Infection | activates | disease | 1.00 |
| IFN | activates | protein | 1.00 |
| CGAS-STING | associated_with | gene | 1.00 |
| Inflammation | activates | disease | 1.00 |
| Neuroinflammation | activates | disease | 1.00 |
| Senescence | activates | disease | 1.00 |
| CGAS | activates | gene | 1.00 |
| Als | associated_with | disease | 1.00 |
| Autophagy | activates | pathway | 1.00 |
| Als | regulates | disease | 1.00 |
| DNA | activates | gene | 1.00 |
| Immune Response | activates | pathway | 1.00 |
| Tumor | activates | disease | 1.00 |
| Cancer | activates | disease | 1.00 |
| Als | inhibits | disease | 1.00 |
| GENES | activates | gene | 1.00 |
| Als | activates | disease | 1.00 |
| Carcinoma | activates | disease | 1.00 |
| Oxidative Stress | activates | pathway | 1.00 |
| Inflammation | therapeutic_target | disease | 1.00 |
| autophagy | activates | pathway | 1.00 |
| CGAS-STING | inhibits | gene | 1.00 |
| AUTOPHAGY | activates | pathway | 1.00 |
| Innate Immunity | regulates | pathway | 1.00 |
| CGAS-STING | therapeutic_target | gene | 1.00 |
| TBK1 | activates | gene | 1.00 |
| P62 | activates | gene | 1.00 |
| Autophagy | regulates | pathway | 1.00 |
| Apoptosis | activates | pathway | 1.00 |
| Innate Immunity | activates | pathway | 1.00 |
| Innate Immune System | involved_in | process | 0.95 |
| neuroinflammation | associated_with | process | 0.95 |
| Type I Interferon Response | regulates | pathway | 0.95 |
| Lysosome Biogenesis | promotes | process | 0.95 |
| ferroptosis | associated_with | process | 0.95 |
| Microglial Dysfunction | promotes | phenotype | 0.95 |
| Motor Neurons | activates | cell_type | 0.95 |
| Neurological Diseases | associated_with | disease | 0.95 |
| Type I Interferon Response | activates | process | 0.95 |
| type I interferon response | activates | process | 0.95 |
| Inflammation | associated_with | disease | 0.95 |
| lysosome biogenesis | promotes | process | 0.95 |
| colon cancer | therapeutic_target | disease | 0.95 |
| Innate Immune Response | activates | process | 0.95 |
| Myocardial Ischemia-Reperfusion Injury | associated_with | disease | 0.95 |
| colitis | therapeutic_target | disease | 0.95 |
| Anti-Tumor Immune Response | activates | process | 0.95 |
| type I interferon | promotes | process | 0.95 |
| Source | Relation | Type | Str |
|---|---|---|---|
| DSDNA | activates | gene | 1.00 |
| INFLAMMATION | inhibits | gene | 1.00 |
| CGAS | activates | protein | 1.00 |
| CYTOKINES | activates | gene | 1.00 |
| IRF3 | activates | gene | 1.00 |
| CGAS | targets | gene | 1.00 |
| TBK1 | activates | gene | 1.00 |
| GPX4 | activates | protein | 1.00 |
| APOPTOSIS | activates | gene | 1.00 |
| CANCER | activates | gene | 1.00 |
| INFLAMMATION | activates | gene | 1.00 |
| MITOCHONDRIAL DNA | activates | gene | 1.00 |
| MTDNA | activates | gene | 1.00 |
| GENES | activates | gene | 1.00 |
| CGAS | inhibits | gene | 1.00 |
| ROS | activates | gene | 1.00 |
| PYROPTOSIS | activates | gene | 1.00 |
| CGAS | regulates | gene | 1.00 |
| Ginkgetin | targets | compound | 0.98 |
| cGAMP | activates | protein | 0.95 |
| Ginkgetin | binds_to | drug | 0.95 |
| SQSTM1 | mediates | entity | 0.95 |
| cGAMP | binds_to | protein | 0.95 |
| Cgas | activates | protein | 0.95 |
| mtDNA leakage | activates | process | 0.95 |
| Ginkgetin | binds | compound | 0.95 |
| STING agonist | activates | drug | 0.95 |
| STING agonists | activates | drug | 0.95 |
| 2'3'-Cgamp | activates | compound | 0.95 |
| P62 | associated_with | protein | 0.90 |
| glutamate excitotoxicity | activates | process | 0.90 |
| 2'3'-cGAMP | activates | compound | 0.90 |
| substance P | inhibits | protein | 0.90 |
| TRIM32 | modifies | protein | 0.90 |
| cytosolic ssDNA | activates | phenotype | 0.90 |
| STIM1 | interacts_with | protein | 0.90 |
| NBR1 | inhibits | protein | 0.90 |
| Stimuli-responsive nanoplatforms | activates | compound | 0.90 |
| cGAS | activates | protein | 0.90 |
| Autophagy | degrades | process | 0.90 |
| Stimuli-responsive Nanoplatforms | activates | compound | 0.90 |
| p62 | activates | protein | 0.90 |
| SQSTM1 | interacts_with | protein | 0.90 |
| TDP43 | activates | entity | 0.90 |
| Ginkgetin | inhibits | compound | 0.90 |
| SNCA pathology | activates | process | 0.90 |
| ADSL | inhibits | gene | 0.90 |
| Alpha-Synuclein | activates | protein | 0.90 |
| CGAS | associated_with | gene | 0.90 |
| Familial Als-Causing Mutations | upregulates | phenotype | 0.90 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
neurodegeneration | 2026-04-08 | 5 hypotheses Top: 0.693
neuroinflammation | 2026-04-07 | 6 hypotheses Top: 0.740
neurodegeneration | 2026-04-07 | 7 hypotheses Top: 0.720
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Single-cell RNA sequencing of microglial states in AD hippocampus | exploratory | Alzheimer's disease | 0.850 | 0.00 | AD mouse hippocampus | proposed | N/A |
| cGAS-STING Pathway Validation Study in Parkinson's Disease | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $7,100,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| The gain-of-function TREM2-T96K mutation increases risk for Alzheimer's disease [PMID:41109213] | Pilat DJ, Le H, Prokopenko D, Lin CJ, Ei | Neuron | 2026 | 0 |
| Role of TREM2 in neuroinflammation. [PMID:41213496] | Abdulkhaliq AA, Alasiri G, Almoghrabi Y, | Exp Neurol | 2026 | 0 |
| Activation of stimulator of interferon genes (STING) and inhibition of vascular [PMID:41380972] | Wang Y, Hou Y, Han J, Zhang Z, Cheng Y e | J Biol Chem | 2026 | 0 |
| cGAS-STING signaling in Alzheimer's disease: Microglial mechanisms and therapeut [PMID:41481960] | Fazal F, Dar NJ, Ahamad S, Khan S, Bano | Mol Aspects Med | 2026 | 0 |
| Opportunities and challenges of targeting cGAS-STING in cancer. [PMID:41486397] | Lu C, Wang W, Fu YX | Nat Rev Cancer | 2026 | 0 |
| Synergistic potential of TREM2 agonists and exercise training in Alzheimer's dis [PMID:41494649] | Zhang J, St Pierre Schneider B, Muguerza | Am J Physiol Endocrinol Metab | 2026 | 0 |
| Inhibiting macrophage-derived lactate transport restores cGAS-STING signalling a [PMID:41495200] | Li D, Cui G, Yang K, Lu C, Jiang Y et al | Nat Cell Biol | 2026 | 0 |
| cGAS-STING activation in Parkinson's Disease: From mechanisms to Disease-Modifyi [PMID:41500413] | Solomon J, Mandal S, Aran KR | Gene | 2026 | 0 |
| Ubiquitination-directed cytosolic DNA degradation governs cGAS-STING-mediated im [PMID:41512867] | Li L, Ye Q, Ma J, Wang Z, Liu T et al. | Cancer Cell | 2026 | 0 |
| Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvir [PMID:41576929] | Mateus-Tique J, Lakshmi A, Singh B, Iyer | Cancer Cell | 2026 | 0 |
| Peripheral cancer attenuates amyloid pathology in Alzheimer's disease via cystat [PMID:41576952] | Li X, Tang X, Zeng J, Duan L, Hou Z et a | Cell | 2026 | 0 |
| TREM2 expression level is critical for microglial state, metabolic capacity and [PMID:41580393] | Feiten AF, Dahm K, Schlepckow K, van Len | Nat Commun | 2026 | 0 |
| DNA-protein cross-links promote cGAS-STING-driven premature aging and embryonic [PMID:41610251] | Tomaskovic I, Prieto-Garcia C, Boskovic | Science | 2026 | 0 |
| Large-scale single-cell analysis and in silico perturbation reveal dynamic evolu [PMID:41617928] | Xia P, Shuang S, Fu D, Liu L, Yang D et | NPJ Precis Oncol | 2026 | 0 |
| Neuronal TLR4 upregulation activates the cGAS-STING pathway to induce ferroptosi [PMID:41702081] | Qin H, Yang L, Du J, Xu X, Chen Z et al. | Int Immunopharmacol | 2026 | 0 |
| Dissecting genetic and immune drivers of heterogeneous responses to neoadjuvant [PMID:41720086] | Zhao Q, Huang R, Wang C, Hu J, Nie R et | Cancer Cell | 2026 | 0 |
| Lock-equipped six-helix DNA bundle-mediated siSTING delivery ameliorates Alzheim [PMID:41742243] | Zhang M, Lan Y, Yue Q, He J, Li L et al. | J Nanobiotechnology | 2026 | 0 |
| STING-NF-κB signaling builds an influenza spillover barrier. [PMID:41747053] | Ye R, Wang S, Hu Y, Pan Y, Zheng W et al | Science | 2026 | 0 |
| The cGAS-STING signaling pathway: A central regulator and novel therapeutic targ [PMID:41765111] | Jiang H, Ji Y, Shang T, Qi L, Li Z et al | Biochem Pharmacol | 2026 | 0 |
| cGAS-STING and PANoptosis: Interplay, Underlying Mechanisms, and Therapeutic Tar [PMID:42016387] | Wang Y, Chen J, Feng W, Li N, Zhang X et | Drug Des Devel Ther | 2026 | 0 |
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.73 · 2026-04-21
closed · Rounds: 4 · Score: 0.73 · 2026-04-21
closed · Rounds: 4 · Score: 0.77 · 2026-04-21
Hypotheses and analyses mentioning STING in their description or question text
Score: 0.691 · neurodegeneration · 2026-04-04
## Molecular Mechanism and Rationale The cyclic GMP-AMP synthase (cGAS) and stimulator of interferon genes (STING) path
Score: 0.660 · neuroinflammation · 2026-04-21
## Mechanistic Overview Chronic cGAS/STING Hyperactivation Drives Progressive Neurodegeneration Through Sustained Type I
Score: 0.637 · Alzheimer's disease · 2026-04-04
## Mechanistic Overview Stage-Selective TREM2 Agonism — Boosting DAM Phagocytosis in Early Amyloid Phase starts from the
Score: 0.630 · neurodegeneration · 2026-04-22
## Mechanistic Overview Epigenetic Bivalency at CDKN2A Locus Distinguishes Senescent from Activated Microglia starts fro
Score: 0.601 · neuroinflammation · 2026-04-15
## Mechanistic Overview STING Antagonism Prevents Acute-to-Chronic Neuroinflammation Transition via Interruption of IFN-
Score: 0.580 · neuroinflammation · 2026-04-21
## Mechanistic Overview Astrocyte cGAS/STING Activation Converts Protective into Destructive Neuroinflammation starts fr
Score: 0.560 · neuroinflammation · 2026-04-21
## Mechanistic Overview Temporal cGAS-STING Activation Stage-Specific Therapeutic Targeting starts from the claim that m
Score: 0.526 · synaptic biology · 2026-04-14
## Mechanistic Overview HCN1-Selective Blockade Normalizes Thalamic Rebound Bursting in P/Q Channel Deficiency starts fr
Score: 0.520 · neurodegeneration · 2026-04-22
## Mechanistic Overview Loss of Nuclear Lamin B1 Distinguishes Senescent Microglia from Inflammatory Activation starts f
Score: 0.520 · neurodegeneration · 2026-04-22
## Mechanistic Overview Mitochondrial DNA Damage and cGAS-STING Activation Induces Microglial Senescence starts from the